Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.96 USD | +2.16% | +0.19% | +39.84% |
01:31pm | Leerink Partners Starts XOMA With Outperform Rating, $40 Price Target | MT |
Apr. 03 | XOMA Corporation completed the acquisition of Kinnate Biopharma Inc.. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.84% | 296M | |
-2.19% | 103B | |
+1.76% | 95.28B | |
+1.46% | 22.15B | |
-15.72% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.84% | 16.05B | |
+5.02% | 13.68B | |
+36.41% | 12.17B |
- Stock Market
- Equities
- XOMA Stock
- News XOMA Corporation
- XOMA Acquires Commercial Payment, Portion of Milestone Rights to Ixinity For $9.6 Million